Engulfment of activated apoptotic cells abolishes TGF-β-mediated immunoregulation via the induction of IL-6

Journal of Immunology

Volumn 194, Issue 4, 2015, Pages 1621-1627

  Notley, Clare A ^a   Brown, Mark A ^a   McGovern, Jenny L ^a   Jordan, Christine K ^a   Ehrenstein, Michael R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTHRITIS; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PROTEIN INDUCTION; PROTEIN SYNTHESIS INHIBITION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CONFOCAL MICROSCOPY; EXPERIMENTAL ARTHRITIS; FLOW CYTOMETRY; IMMUNOLOGY; INFLAMMATION; MACROPHAGE; PHAGOCYTOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; DENDRITIC CELLS; FLOW CYTOMETRY; INFLAMMATION; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; PHAGOCYTOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84922511637     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401256     Document Type: Article

References (34)

1. Henson, P. M., and D. A. Hume. 2006. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol. 27: 244-250.
2. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-βeta, PGE2, and PAF. J. Clin. Invest. 101: 890-898.
3. Voll, R. E., M. Herrmann, E. A. Roth, C. Stach, J. R. Kalden, and I. Girkontaite. 1997. Immunosuppressive effects of apoptotic cells. Nature 390: 350-351.
4. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2: 965-975.
5. Muñoz, L. E., K. Lauber, M. Schiller, A. A. Manfredi, and M. Herrmann. 2010. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat. Rev. Rheumatol. 6: 280-289.
6. McGaha, T. L., Y. Chen, B. Ravishankar, N. van Rooijen, and M. C. I. Karlsson. 2011. Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. Blood 117: 5403-5412.
7. Miyake, Y., K. Asano, H. Kaise, M. Uemura, M. Nakayama, and M. Tanaka. 2007. Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens. J. Clin. Invest. 117: 2268-2278.
8. Steinman, R. M., S. Turley, I. Mellman, and K. Inaba. 2000. The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 191: 411-416.
9. Morelli, A. E., A. T. Larregina, W. J. Shufesky, A. F. Zahorchak, A. J. Logar, G. D. Papworth, Z. Wang, S. C. Watkins, L. D. Falo, Jr., and A. W. Thomson. 2003. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101: 611-620.
10. Gray, M., K. Miles, D. Salter, D. Gray, and J. Savill. 2007. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl. Acad. Sci. USA 104: 14080-14085.
11. Torchinsky, M. B., J. Garaude, A. P. Martin, and J. M. Blander. 2009. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458: 78-82.
12. Inzkirweli, N., B. Gückel, C. Sohn, D. Wallwiener, G. Bastert, and M. Lindner. 2007. Antigen loading of dendritic cells with apoptotic tumor cell-preparations is superior to that using necrotic cells or tumor lysates. Anticancer Res. 27(4B): 2121-2129.
13. Feng, H., Y. Zeng, M. W. Graner, and E. Katsanis. 2002. Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood 100: 4108-4115.
14. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392: 86-89.
15. Fry, T. J., J. L. Shand, M. Milliron, S. K. Tasian, and C. L. Mackall. 2009. Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches. Cancer Immunol. Immun-other. 58: 1257-1264.
16. Frank, M. O., J. Kaufman, S. Tian, M. Suárez-Fariñas, S. Parveen, N. E. Blachère, M. J. Morris, S. Slovin, H. I. Scher, M. L. Albert, and R. B. Darnell. 2010. Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer. PLoS ONE 5: 5.
17. Propato, A., G. Cutrona, V. Francavilla, M. Ulivi, E. Schiaffella, O. Landt, R. Dunbar, V. Cerundolo, M. Ferrarini, and V. Barnaba. 2001. Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-priming. Nat. Med. 7: 807-813.
18. Notley, C. A., M. A. Brown, G. P. Wright, and M. R. Ehrenstein. 2011. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J. Immunol. 186: 4967-4972.
19. Kushwah, R., J. R. Oliver, J. Zhang, K. A. Siminovitch, and J. Hu. 2009. Ap-optotic dendritic cells induce tolerance in mice through suppression of dendritic cell maturation and induction of antigen-specific regulatory T cells. J. Immunol. 183: 7104-7118.
20. Païdassi, H., M. Acharya, and A. Lacy-Hulbert. 2010. Alpha (v) integrins license regulatory T cells to apoptotic cells and self-associated antigens. Ann. N. Y. Acad. Sci. 1209: 68-76.
21. Wong, P. K. K., J. M. W. Quinn, N. A. Sims, A. van Nieuwenhuijze, I. K. Campbell, and I. P. Wicks. 2006. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum. 54: 158-168.
22. Koenders, M. I., E. Lubberts, B. Oppers-Walgreen, L. van den Bersselaar, M. M. Helsen, F. E. Di Padova, A. M. Boots, H. Gram, L. A. Joosten, and W. B. van den Berg. 2005. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am. J. Pathol. 167: 141-149.
23. Pinto, L. G., T. M. Cunha, S. M. Vieira, H. P. Lemos, W. A. Verri, Jr., F. Q. Cunha, and S. H. Ferreira. 2010. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice. Pain 148: 247-256.
24. Kushwah, R., J. Wu, J. R. Oliver, G. Jiang, J. Zhang, K. A. Siminovitch, and J. Hu. 2010. Uptake of apoptotic DC converts immature DC into tolerogenic DC that induce differentiation of Foxp3+ Treg. Eur. J. Immunol. 40: 1022-1035.
25. Miles, K., J. Heaney, Z. Sibinska, D. Salter, J. Savill, D. Gray, and M. Gray. 2012. A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc. Natl. Acad. Sci. USA 109: 887-892.
26. Ravishankar, B., R. Shinde, H. Liu, K. Chaudhary, J. Bradley, H. P. Lemos, P. Chandler, M. Tanaka, D. H. Munn, A. L. Mellor, and T. L. McGaha. 2014. Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance. Proc. Natl. Acad. Sci. USA 111: 4215-4220.
27. Griffith, T. S., and T. A. Ferguson. 2011. Cell death in the maintenance and abrogation of tolerance: the five Ws of dying cells. Immunity 35: 456-466.
28. Magna, M., and D. S. Pisetsky. 2014. The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. Mol. Med. 20: 138-146.
29. Yamana, J., M. Yamamura, A. Okamoto, T. Aita, M. Iwahashi, K. Sunahori, and H. Makino. 2004. Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytokine signaling 1 in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res. Ther. 6: R567-R577.
30. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
31. Di Caro, V., B. Phillips, C. Engman, J. Harnaha, M. Trucco, and N. Giannoukakis. 2013. Retinoic acid-producing, ex-vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes. Clin. Exp. Immunol. 174: 302-317.
32. Di Caro, V., B. Phillips, C. Engman, J. Harnaha, M. Trucco, and N. Giannoukakis. 2014. Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice. PLoS ONE 9: e83575.
33. Natarajan, P., A. Singh, J. T. McNamara, E. R. Secor, Jr., L. A. Guernsey, R. S. Thrall, and C. M. Schramm. 2012. Regulatory B cells from hilar lymph nodes of tolerant mice in a murine model of allergic airway disease are CD5+, express TGF-β, and co-localize with CD4+Foxp3+ T cells. Mucosal Immunol. 5: 691-701.
34. Snir, A., A. Kessel, T. Haj, I. Rosner, G. Slobodin, and E. Toubi. 2011. Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy. Clin. Exp. Rheu-matol. 29: 697-700.